Cargando…

Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity

Detalles Bibliográficos
Autor principal:	Núñez, Isaac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890755/ https://www.ncbi.nlm.nih.gov/pubmed/35247309 http://dx.doi.org/10.1016/S0140-6736(22)00164-7

Ejemplares similares

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

A step backwards in the fight against global vaccine inequities
por: Aryeetey, Ernest, et al.
Publicado: (2021)

Refugee access to COVID-19 vaccines in Lebanon
por: Jawad, Nadine K, et al.
Publicado: (2021)

Ensure Palestinians have access to COVID-19 vaccines
por: Martin, Steven, et al.
Publicado: (2021)

Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022)

Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants
por: Dhawan, Manish, et al.
Publicado: (2021)

Hospitals and Approved Societies
por: Dunstan, S.
Publicado: (1923)

Accessing first doses of mpox vaccine made available in Victoria, Australia
por: Chow, Eric P.F., et al.
Publicado: (2023)

Brand inequity in access to COVID-19 vaccines
por: Sheel, Meru, et al.
Publicado: (2022)

Addressing vaccine inequity: African agency and access to COVID-19 vaccines
por: Soulé, Folashadé
Publicado: (2022)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Michelli, P. J.
Publicado: (1922)

Migrant health is public health: a call for equitable access to COVID-19 vaccines
por: Al-Oraibi, Amani, et al.
Publicado: (2021)

The Vaccination Papers Approved
por: Dillingham, Thomas M.
Publicado: (1898)

The relevance of dengue virus genotypes surveillance at country level before vaccine approval
por: Usme-Ciro, José A, et al.
Publicado: (2014)

Edinburgh Royal Infirmary and Approved Societies
por: Caw, Wm. S.
Publicado: (1922)

Section 12 approval: fit for purpose?
por: Gupta, Nidhi, et al.
Publicado: (2020)

Section 12 approval: fit for purpose?
por: Ballantyne-Watts, Darryl
Publicado: (2020)

Vaccination and Re-Vaccination
por: Sen, Nibaran Chandra
Publicado: (1914)

Ensuring global access to COVID-19 vaccines: deployment strategies for refugees and migrants must not be forgotten
por: Buonsenso, Danilo, et al.
Publicado: (2021)

Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty
por: Sparke, Matthew, et al.
Publicado: (2022)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant
por: Toya, Takashi, et al.
Publicado: (2022)

Association of Vaccine Confidence and Hesitancy in Three Phases of COVID-19 Vaccine Approval and Introduction in Japan
por: Tokiya, Mikiko, et al.
Publicado: (2022)

Do the Approved Societies Seek to Control the Doctors?
por: Ward, Gordon
Publicado: (1922)

Research approvals iceberg: helping it melt away
por: Kolstoe, Simon E., et al.
Publicado: (2019)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
por: Tumban, Ebenezer
Publicado: (2020)

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines
por: Sanvictores, Diozele Hazel M, et al.
Publicado: (2012)

Sex-disaggregated data in COVID-19 vaccine trials
por: Vijayasingham, Lavanya, et al.
Publicado: (2021)

Serological assessment is advisable before COVID-19 vaccination
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Before blaming SARS-CoV-2 vaccines for thalamic lacunar stroke, alternative etiologies must be ruled out
por: Finsterer, Josef
Publicado: (2023)

Vaccination
Publicado: (1886)

Trial participants' rights after authorisation of COVID-19 vaccines
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Withholding methotrexate after COVID-19 vaccination: different strategies, same results?
por: De Medeiros-Ribeiro, Ana C, et al.
Publicado: (2022)

The approval of the first malaria vaccine: The beginning of the end of the malaria epidemic
por: Olufadewa, Isaac, et al.
Publicado: (2022)

New Results Will Change the Paradigm for Phase I Trials and Drug Approval
por: Chabner, Bruce A.
Publicado: (2010)

Incidental inequity
por: Nowak, Kristen J., et al.
Publicado: (2018)

Access, an unintended consequence of virtual continuing medical education during COVID-19: a department's experience at the University of Toronto
por: Kisilevsky, Eli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rucgkeoj0drug62gu03ar6saip